Aims and scope
Applied Cancer Research is an open access, peer-reviewed journal focused on clinical, surgical and translational research in the field of oncology. The journal considers for publication original articles addressing genetics, pathology, immuno-oncology, microbiome, bioinformatics, diagnosis, treatment, patient care, and population sciences of cancer.
As a multidisciplinary journal, Applied Cancer Research aims to be a forum for exchanging relevant information among researchers, health care practitioners and health policy makers, helping them enhance prevention and decrease mortality rates from malignant diseases, improve the management of patients afflicted by them and the quality of life of people during and after treatment.
All articles published by Applied Cancer Research are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Applied Cancer Research you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
The publication costs for Applied Cancer Research are covered by the A.C.Camargo Cancer Center, so authors do not need to pay an article-processing charge for each article accepted for publication.
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
We are working closely with relevant indexing services including PubMed Central and Web of Science (Clarivate Analytics) to ensure that articles published in Applied Cancer Research will be available in their databases when appropriate.
Applied Cancer Research operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication.
Edited by José Vassallo, a decision will be reached based on these reports, supported by an expert Editorial Board.
Authors will be able to check the progress of their manuscript at any time by logging into the journal's submission system.
All manuscripts submitted to Applied Cancer Research should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Citing articles in Applied Cancer Research
Articles in Applied Cancer Research should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Appl Cancer Res [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Appl Cancer Res 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.
Why publish your article in Applied Cancer Research
Applied Cancer Research's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Applied Cancer Research offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in Applied Cancer Research gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Applied Cancer Research are included in article alerts and regular email updates. Some may be highlighted on Applied Cancer Research’s pages and on the BioMed Central homepage.
In addition, articles published in Applied Cancer Research may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Applied Cancer Research. A list of articles recently press-released by journals published by BioMed Central is available here.
As an author of an article published in Applied Cancer Research you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.
- Editorial Board
- Sign up for article alerts and news from this journal
2017 Journal Metrics
47 days from submission to first decision
143 days from submission to acceptance
31 days from acceptance to publication
28 Altmetric Mentions